- Home
- LNKS vs PHIO Comparison
LNKS vs PHIO Comparison
Compare LNKS & PHIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNKS
- PHIO
- Stock Information
- Founded
- LNKS 1995
- PHIO 2011
- Country
- LNKS Malaysia
- PHIO United States
- Employees
- LNKS N/A
- PHIO N/A
- Industry
- LNKS
- PHIO Biotechnology: Pharmaceutical Preparations
- Sector
- LNKS
- PHIO Health Care
- Exchange
- LNKS NYSE
- PHIO Nasdaq
- Market Cap
- LNKS 8.7M
- PHIO 8.6M
- IPO Year
- LNKS 2024
- PHIO N/A
- Fundamental
- Price
- LNKS $0.55
- PHIO $2.16
- Analyst Decision
- LNKS
- PHIO Strong Buy
- Analyst Count
- LNKS 0
- PHIO 2
- Target Price
- LNKS N/A
- PHIO $9.00
- AVG Volume (30 Days)
- LNKS 261.6K
- PHIO 703.0K
- Earning Date
- LNKS 08-11-2025
- PHIO 08-13-2025
- Dividend Yield
- LNKS N/A
- PHIO N/A
- EPS Growth
- LNKS N/A
- PHIO N/A
- EPS
- LNKS N/A
- PHIO N/A
- Revenue
- LNKS $5,088,489.00
- PHIO N/A
- Revenue This Year
- LNKS N/A
- PHIO N/A
- Revenue Next Year
- LNKS N/A
- PHIO N/A
- P/E Ratio
- LNKS N/A
- PHIO N/A
- Revenue Growth
- LNKS N/A
- PHIO N/A
- 52 Week Low
- LNKS $0.45
- PHIO $0.97
- 52 Week High
- LNKS $10.27
- PHIO $9.79
- Technical
- Relative Strength Index (RSI)
- LNKS N/A
- PHIO 50.19
- Support Level
- LNKS N/A
- PHIO $2.11
- Resistance Level
- LNKS N/A
- PHIO $2.30
- Average True Range (ATR)
- LNKS 0.00
- PHIO 0.21
- MACD
- LNKS 0.00
- PHIO -0.04
- Stochastic Oscillator
- LNKS 0.00
- PHIO 9.65
About LNKS LINKERS INDUSTRIES LIMITED
Linkers Industries Ltd is a company which acts as a manufacturer and a supplier of wire, cable harnesses with their manufacturing operations in Malaysia. Wire/cable harness refers to an assembly of wires/cables bound together with straps, cable ties and electrical tapes to transmit signals or electrical power. Company works closely with customers in each stage of a product's life cycle, including design, prototyping and production. Geographically company provides services in Thailand, Malaysia, Switzerland, United States of America, and many others, maximum revenue gained from Thailand.
About PHIO Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.